Edwardsiella piscicida has emerged as an important pathogen of channel × blue catfish hybrids cultured in the southeastern United States. With increasing popularity of hybrid catfish and growing concern over E. piscicida, the crossprotective potential of a live‐attenuated E.ictaluri vaccine was evaluated. An immunization bath of E. piscicida (3 × 107 CFU/ml) protected channel catfish against immersion challenge of wild‐type E. ictaluri (1 × 107 CFU/ml) across multiple temperatures and feeding regimens (relative percent survival [RPS]: 89–100%). Channel catfish immunized orally with a live‐attenuated E. ictaluri vaccine/feed admix (3 × 107 CFU/g of feed) were protected against intracoelomic injections of both high (HD) (7.4x105 CFU/fish; RPS = 85%) and low doses (LD) (1.5 × 105 CFU/fish; RPS = 88%) of E. piscicida. Because of limited feed consumption during vaccination, oral immunization of hybrids was followed by a 30‐min immersion bath with cultured vaccine (5 × 106 CFU/ml). Combinatory oral/bath vaccination was ineffective against HD E. piscicida but was protective against LD E. piscicida (48% RPS) and E. ictaluri (96% RPS). Finally, naïve catfish that survived LD E. piscicida injections were protected against E. ictaluri immersion challenge (2 × 107 CFU/ml; RPS: Hybrids 55%; Channels 75%). Results suggest a live‐attenuated E. ictaluri vaccine can also protect channel and hybrid catfish against E. piscicida.
No takes yet. Share an insight, caveat, or question.
Griffin et al. (2020) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: